A sign for Eli Lilly & Co. sits outside their corporate headquarters in Indianapolis on April 26, 2017.The company said Wednesday, May 3, 2023, that its experimental Alzheimer's drug appeared to slow worsening of the mind-robbing disease in a large study.Darron Cummings/AP WASHINGTON Eli Lilly and Co. said Wednesday its experimental Alzheimer's drug appeared to slow worsening of the mind-robbing disease in a large study.
[
add
]
[
|
|
...
]